Medirom Healthcare Technologies Inc. current report, Q4 FY2022

Business Context and Reporting Period

Medirom Healthcare Technologies Inc., a Japanese foreign private issuer, filed this Form 6-K for December 2022. The filing reports changes to the Company’s independent registered public accounting firm.

Key Financial Metrics

The filing does not provide revenue, profit, cash flow, margins, debt, liquidity, or other operating or financial metrics.

Material Changes

  • On December 12, 2022, Baker Tilly US, LLP notified the Company that it declined to stand for re-election as independent registered public accounting firm, effective immediately.
  • The Board confirmed the termination on December 12, 2022.
  • The Company reported no disagreements with Baker Tilly regarding accounting principles or practices, financial statement disclosure, or audit scope and procedures during the two fiscal years ended December 31, 2021 and the subsequent interim period through December 12, 2022.
  • The Company also reported no reportable events during that period.
  • On December 15, 2022, the Audit Committee recommended, and the Board approved, the appointment of TAAD LLP as independent registered public accounting firm to audit the consolidated financial statements for the fiscal year ending December 31, 2022.
  • The Company stated that it had not consulted TAAD LLP during the relevant period regarding accounting principles, potential audit opinions, disagreements, or reportable events.

Guidance, Risks, and Unusual Items

The filing contains no financial guidance or business outlook. The change in auditor is the principal reported corporate governance and reporting event. Baker Tilly was requested to provide the SEC with a letter stating whether it agrees with the Company’s disclosures; that letter was furnished as Exhibit 16.1.

Investor Verification Items

  • Review Exhibit 16.1 for Baker Tilly’s response to the Company’s statements.
  • Verify TAAD LLP’s audit conclusions for the fiscal year ended December 31, 2022.
  • Confirm whether subsequent filings identify any audit qualification, internal-control issue, disagreement, or reportable event.